Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibros...
The US Food and Drug Administration (US FDA) and European Medicines Agency (EMA) approved Johnson & Johnson’s ...
Thomas Willemsen, Senior Vice President, Takeda Asia Pacific It's estimated that one in three people in developin...
111, Inc., a leading tech-enabled healthcare platform company in China, has signed a strategic cooperation agreement on ...
Overland Pharmaceuticals, a premier biopharmaceutical company bringing innovative medicines to patients in Asia and worl...
The Therapeutic Goods Administration (TGA) in Australia has granted provisional approval to AstraZeneca for its tixagevi...
CANbridge Pharmaceuticals, Inc. has announced that CAN108 (maralixibat), a treatment for Alagille syndrome (ALGS), has b...
Alvotech Holdings S.A., a global biopharmaceutical company focused solely on the development and manufacture of biosimil...
At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharma...
Honeywell has announced a commercial partnership with AstraZeneca to develop and bring to market next-generation re...
China's drug regulator National Medical Products Administration (NMPA) has granted conditional approval for the imports ...
Celltrion Group, based in South Korea, has submitted an Investigational New Drug (IND) application to conduct a global P...
Indian firm Dr Reddy's Laboratories has entered into a definitive agreement to acquire Nimbus Health GmbH, a licens...
In today's pharmaceutical industry, disruptive technologies such as the Internet of Things (IoT) and artificial intellig...
Novartis has signed a Memorandum of Understanding (MoU) with Aster DM Healthcare, one of the largest integrated health...
Beroni Group, an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati...
The Indian Institute of Technology Madras and Krea University, Chennai, conducted a study that can help s...
The Therapeutic Goods Administration (TGA) in Australia has issued provisional approval of the first oral treatments for...
Netherlands-based argenx SE has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved ...
India-based Glenmark Pharmaceuticals has announced that its Swiss subsidiary, Glenmark Specialty, has entered into an ex...
Japan-based pharmaceutical firm Daiichi Sankyo has entered into an agreement with Cosette Pharmaceuticals, Inc. whereby ...
IQVIA has come up with the key trends that emerging biotech and emerging biopharma companies should look out for in 2022...
India-based Lupin has entered into a partnership with Shenzhen Foncoo Pharmaceutical Co Ltd (Foncoo). This is Lupin&rsqu...
Australian firm Cogstate, via its global commercial partner Eisai has announced that Cogstate technology will be markete...
Takeda Pharmaceutical Company has announced the exercise of its option to acquire Adaptate Biotherapeutics, a UK-based c...
